Quality of fixed dose artemether/lumefantrine products in Jimma Zone, Ethiopia
Open Access
- 15 July 2019
- journal article
- research article
- Published by Springer Nature in Malaria Journal
- Vol. 18 (1) , 1-11
Abstract
Malaria caused by Plasmodium vivax and Plasmodium falciparum is among the major public health problems in most endemic areas of the world. Artemisinin-based combination therapy (ACT) has been recommended as a first-line treatment for uncomplicated Plasmodium falciparum malaria almost in all endemic regions. Since ineffectively regulated medicines in resource limited settings could favour infiltration of poor quality anti-malarial medicines into pharmaceutical supply chain and jeopardize a positive treatment outcome, regular monitoring of the quality of anti-malarial medicines is critical. Thus, the aim of this study was to assess the quality of fixed dose combination (FDC) artemether (ART)/lumefantrine (LUM) tablets available in Jimma zone, Ethiopia. This study was conducted in Jimma zone, Ethiopia. A total of 74 samples of FDC ART/LUM (20 mg ART/120 mg LUM) tablets were collected from 27 public facilities. All samples were subjected to visual inspection and the relevant information was recorded. The samples were transported to Jimma University Laboratory of Drug Quality (JuLaDQ) and stored at ambient temperature (20 °C to 25 °C) until analysis. The Pharmacopoeial conform/non-conform methods and the risk-based Derringer’s desirability function approach were employed to assess the pharmaceutical quality of the investigated products. The visual inspection results revealed that there were no signs of falsified in the investigated products. Identification test results of samples indicated that all samples contained the stated active pharmaceutical ingredients (APIs). The results of uniformity of mass indicated that all samples complied with International Pharmacopoeial specification limits. The assay results, expressed as percent label claim (%lc) of ART (89.8 to 108.8%, mean ± SD = 99.1 ± 3.9%) and LUM (90.0 to 111.9%, mean ± SD = 98.2 ± 3.8%) revealed that, all samples complied with International Pharmacopoeia acceptance specification limits (i.e. 90–110%lc), except one generic product (IPCA Laboratories Ltd., India) which contains excessive LUM (111.9 ± 1.7%lc). The risk priority number (RPN) results revealed that assay (RPN = 392) is relatively the most critical quality attribute followed by identity (RPN = 280) and mass uniformity (40). Quality evaluation based on psycho-physical Harrington’s scale revealed that more than 96% of samples were within the acceptable ranges (D ≥ 0.7–1.0). Both Pharmacopoeial and risk-based desirability function approaches to quality evaluation applied to the investigated products revealed that above 96% FDC ART/LUM tablets circulating in public settings of Jimma zone are of good quality.Keywords
This publication has 37 references indexed in Scilit:
- Fake anti-malarials: start with the factsMalaria Journal, 2016
- The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015Nature, 2015
- Monitoring changes in malaria epidemiology and effectiveness of interventions in Ethiopia and Uganda: Beyond Garki Project baseline surveyMalaria Journal, 2015
- Estimated Under-Five Deaths Associated with Poor-Quality Antimalarials in Sub-Saharan AfricaThe American Journal of Tropical Medicine and Hygiene, 2015
- Time Series Analysis of Trends in Malaria Cases and Deaths at Hospitals and the Effect of Antimalarial Interventions, 2001–2011, EthiopiaPLOS ONE, 2014
- Distribution and utilization of vector control strategies in a malarious village of Jabi Tehnan District, north-western EthiopiaMalaria Journal, 2014
- Mind the gaps - the epidemiology of poor-quality anti-malarials in the malarious world - analysis of the WorldWide Antimalarial Resistance Network databaseMalaria Journal, 2014
- Poor-quality antimalarial drugs in southeast Asia and sub-Saharan AfricaThe Lancet Infectious Diseases, 2012
- Indoor residual spray and insecticide-treated bednets for malaria control: theoretical synergisms and antagonismsJournal of The Royal Society Interface, 2010
- Protective efficacy of interventions for preventing malaria mortality in children in Plasmodium falciparum endemic areasInternational Journal of Epidemiology, 2010